StockMarketWire.com - Shore Capital today initiates coverage of Verona Pharma PLC [LON:VRP] with a buy investment rating and price target of 173p.

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk